4//SEC Filing
White Anne E. 4
Accession 0000059478-23-000069
CIK 0000059478other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 5:12 PM ET
Size
9.7 KB
Accession
0000059478-23-000069
Insider Transaction Report
Form 4
White Anne E.
EVP & Pres, Lilly Neuroscience
Transactions
- Award
Common Stock
2023-02-10$345.12/sh+8,562$2,954,917→ 62,926 total - Sale
Common Stock
2023-02-10$342.76/sh−2,500$856,900→ 60,426 total - Sale
Common Stock
2023-02-13$346.47/sh−2,500$866,175→ 57,926 total - Award
Restricted Stock Unit
2023-02-10+4,124→ 4,124 totalFrom: 2024-02-01Exp: 2024-02-01→ Common Stock (4,124 underlying)
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 2, 2022.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.
Documents
Issuer
ELI LILLY & Co
CIK 0000059478
Entity typeother
Related Parties
1- filerCIK 0001752313
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 5:12 PM ET
- Size
- 9.7 KB